chelerythrine has been researched along with Triple Negative Breast Neoplasms in 1 studies
chelerythrine : A benzophenanthridine alkaloid isolated from the root of Zanthoxylum simulans, Chelidonium majus L., and other Papaveraceae.
Triple Negative Breast Neoplasms: Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, W | 1 |
| Huang, J | 1 |
| Yuan, Z | 1 |
| Feng, S | 1 |
| Xie, Y | 1 |
| Ma, W | 1 |
1 other study available for chelerythrine and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Protein kinase C inhibitor chelerythrine selectively inhibits proliferation of triple-negative breast cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzophenanthridines; Cell Cycle; Cell Line, Tumor; Cell | 2017 |